Kacital

Potassium citrate, the active ingredient in Kacital, is an alkalinizing agent presented as an oral formulation for oral use. It helps correct potassium deficiency, alkalinize urine, and manage metabolic acidosis in appropriate patients, and is employed in clinical settings to reduce calcium oxalate stone formation.

GNH USA supplies Kacital as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kacital (potassium citrate) is used in conditions where potassium balance or urinary alkalinity is clinically relevant. - Hypokalemia: restores low serum potassium levels, supporting normal cellular function. - Calcium oxalate kidney stones: alkalinizes urine to reduce stone formation and recurrence. - Metabolic acidosis: supplies bicarbonate precursors to correct systemic acid‑base disturbances.

Potassium citrate may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: cramping or bloating. - Diarrhea: loose stools, especially at higher doses. - Taste alteration: metallic or salty taste perception.

Serious or Rare Side Effects: - Hyperkalemia: elevated serum potassium that can affect cardiac rhythm. - Metabolic alkalosis: excessive bicarbonate leading to high blood pH. - Kidney stone aggravation: rare cases of stone formation despite therapy. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing potassium citrate, clinicians should consider several safety measures to minimize risk. - Assess serum potassium: confirm deficiency before initiating therapy. - Monitor renal function: adjust dose in impaired kidney clearance. - Evaluate acid‑base status: avoid in patients with existing alkalosis. - Review concomitant potassium‑sparing agents: reduce risk of hyperkalemia. - Caution in cardiac disease: monitor ECG if high potassium levels develop. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture.

Potassium citrate can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - ACE inhibitors or ARBs: combined effect may cause dangerous hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can alter digoxin toxicity risk. - NSAIDs: may reduce renal potassium excretion, increasing serum levels. - Antibiotics such as trimethoprim‑sulfamethoxazole: can raise potassium concentrations.